166 related articles for article (PubMed ID: 22200403)
1. Analogs of pentamidine as potential anti-Pneumocystis chemotherapeutics.
Maciejewska D; Zabinski J; Kaźmierczak P; Rezler M; Krassowska-Świebocka B; Collins MS; Cushion MT
Eur J Med Chem; 2012 Feb; 48():164-73. PubMed ID: 22200403
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.
Cushion MT; Walzer PD; Ashbaugh A; Rebholz S; Brubaker R; Vanden Eynde JJ; Mayence A; Huang TL
Antimicrob Agents Chemother; 2006 Jul; 50(7):2337-43. PubMed ID: 16801410
[TBL] [Abstract][Full Text] [Related]
3. Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.
Cushion MT; Walzer PD; Collins MS; Rebholz S; Vanden Eynde JJ; Mayence A; Huang TL
Antimicrob Agents Chemother; 2004 Nov; 48(11):4209-16. PubMed ID: 15504843
[TBL] [Abstract][Full Text] [Related]
4. In vitro screening of pentamidine analogs against bacterial and fungal strains.
Maciejewska D; Żabiński J; Kaźmierczak P; Wójciuk K; Kruszewski M; Kruszewska H
Bioorg Med Chem Lett; 2014 Jul; 24(13):2918-23. PubMed ID: 24830598
[TBL] [Abstract][Full Text] [Related]
5. Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia.
Vanden Eynde JJ; Mayence A; Huang TL; Collins MS; Rebholz S; Walzer PD; Cushion MT
Bioorg Med Chem Lett; 2004 Sep; 14(17):4545-8. PubMed ID: 15357989
[TBL] [Abstract][Full Text] [Related]
6. Pentamidine congeners. 2. 2-butene-bridged aromatic diamidines and diimidazolines as potential anti-Pneumocystis carinii pneumonia agents.
Donkor IO; Tidwell RR; Jones SK
J Med Chem; 1994 Dec; 37(26):4554-7. PubMed ID: 7799405
[TBL] [Abstract][Full Text] [Related]
7. Probing the relationship between anti-Pneumocystis carinii activity and DNA binding of bisamidines by molecular dynamics simulations.
Żołek T; Maciejewska D; Żabiński J; Kaźmierczak P; Rezler M
Molecules; 2015 Apr; 20(4):5942-64. PubMed ID: 25854757
[TBL] [Abstract][Full Text] [Related]
8. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.
Jones SK; Hall JE; Allen MA; Morrison SD; Ohemeng KA; Reddy VV; Geratz JD; Tidwell RR
Antimicrob Agents Chemother; 1990 Jun; 34(6):1026-30. PubMed ID: 2393262
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental Pneumocystis carinii pneumonia with analogs of pentamidine.
Tidwell RR; Kilgore SG; Ohemeng KA; Geratz JD; Hall JE
J Protozool; 1989; 36(1):74S-76S. PubMed ID: 2785206
[TBL] [Abstract][Full Text] [Related]
10. Development of highly active anti-
Maciejewska D; Żabiński J; Rezler M; Kaźmierczak P; Collins MS; Ficker L; Cushion MT
Medchemcomm; 2017 Oct; 8(10):2003-2011. PubMed ID: 30108719
[TBL] [Abstract][Full Text] [Related]
11. 1,5-Bis(4-amidinophenoxy)pentane (pentamidine) is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 binding sites.
Wood DH; Hall JE; Rose BG; Tidwell RR
Eur J Pharmacol; 1998 Jul; 353(1):97-103. PubMed ID: 9721046
[TBL] [Abstract][Full Text] [Related]
12. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
Tidwell RR; Jones SK; Geratz JD; Ohemeng KA; Cory M; Hall JE
J Med Chem; 1990 Apr; 33(4):1252-7. PubMed ID: 2319567
[TBL] [Abstract][Full Text] [Related]
13. 2,4-Diphenyl furan diamidines as novel anti-Pneumocystis carinii pneumonia agents.
Francesconi I; Wilson WD; Tanious FA; Hall JE; Bender BC; Tidwell RR; McCurdy D; Boykin DW
J Med Chem; 1999 Jun; 42(12):2260-5. PubMed ID: 10377232
[TBL] [Abstract][Full Text] [Related]
14. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
15. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
[TBL] [Abstract][Full Text] [Related]
16. Bisbenzamidines as antifungal agents. are both amidine functions required to observe an anti-Pneumocystis carinii activity?
Laurent J; Stanicki D; Huang TL; Dei-Cas E; Pottier M; Aliouat el M; Vanden Eynde JJ
Molecules; 2010 Jun; 15(6):4283-93. PubMed ID: 20657441
[TBL] [Abstract][Full Text] [Related]
17. Baicalin tetrazole acts as anti-pneumocystis carinii pneumonia candidate in immunosuppressed rat model.
Chen L; Zhang X; Peng X; Yang Y; Yu H
Microb Pathog; 2019 Jul; 132():59-65. PubMed ID: 31002962
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.
Aviles P; Aliouat EM; Martinez A; Dei-Cas E; Herreros E; Dujardin L; Gargallo-Viola D
Antimicrob Agents Chemother; 2000 May; 44(5):1284-90. PubMed ID: 10770763
[TBL] [Abstract][Full Text] [Related]
20. Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome.
Porollo A; Meller J; Joshi Y; Jaiswal V; Smulian AG; Cushion MT
Curr Drug Targets; 2012 Nov; 13(12):1575-85. PubMed ID: 22934582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
